13 | Cisplatin (Platino)FDA LinkGeneric
03/2014
-
07/2000 |
9 | PlatinumIBA
03/2014
-
07/2000 |
9 | Pharmaceutical PreparationsIBA
03/2014
-
05/2000 |
9 | Paclitaxel (Taxol)FDA LinkGeneric
01/2005
-
05/2000 |
6 | DNA (Deoxyribonucleic Acid)IBA
01/2010
-
05/2000 |
6 | Topotecan (Hycamtin)FDA LinkGeneric
01/2005
-
10/2000 |
4 | Taxoids (Taxanes)IBA
06/2001
-
05/2000 |
3 | 3- (4'- hydroxy- 3'- adamantylbiphenyl- 4- yl)acrylic acidIBA
09/2007
-
03/2004 |
3 | BBR 3464 (BBR3464)IBA
04/2004
-
07/2000 |
3 | Proteins (Proteins, Gene)FDA Link
08/2002
-
08/2000 |
3 | Member 1 Subfamily B ATP Binding Cassette TransporterIBA
12/2001
-
08/2001 |
3 | IDN 5109 (BAY 59-8862)IBA
12/2001
-
05/2000 |
3 | taxaneIBA
12/2001
-
06/2001 |
2 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2014
-
12/2004 |
2 | EnzymesIBA
05/2013
-
01/2006 |
2 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2013
-
12/2001 |
2 | RetinoidsIBA
09/2007
-
03/2004 |
2 | gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
01/2006
-
08/2000 |
2 | Glutathione (Reduced Glutathione)IBA
01/2006
-
08/2000 |
2 | IDN 5390IBA
04/2004
-
03/2003 |
2 | Complementary DNA (cDNA)IBA
04/2004
-
08/2002 |
2 | Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2003
-
08/2002 |
2 | Platinum Compounds (Compounds, Platinum)IBA
12/2002
-
12/2000 |
2 | ST 1481 (Gimatecan)IBA
10/2001
-
08/2001 |
2 | Doxorubicin (Adriamycin)FDA LinkGeneric
08/2001
-
01/2001 |
2 | Oxidants (Oxidizing Agents)IBA
07/2001
-
08/2000 |
2 | Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
07/2001
-
08/2000 |
2 | AnthracyclinesIBA
04/2001
-
01/2001 |
2 | Antineoplastic Agents (Antineoplastics)IBA
07/2000
-
05/2000 |
1 | Adenosine Triphosphate (ATP)IBA
03/2014 |
1 | Drug CombinationsIBA
03/2014 |
1 | LigandsIBA
03/2014 |
1 | SST 0001IBA
05/2013 |
1 | Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2013 |
1 | AnticoagulantsIBA
05/2013 |
1 | Angiogenesis InhibitorsIBA
05/2013 |
1 | Heparin (Liquaemin)FDA LinkGeneric
05/2013 |
1 | heparanaseIBA
05/2013 |
1 | Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
05/2013 |
1 | Conditioned Culture MediaIBA
05/2013 |
1 | Tyrosine (L-Tyrosine)FDA Link
05/2013 |
1 | PoisonsIBA
01/2010 |
1 | ATP-Binding Cassette Transporters (ABC Transporters)IBA
08/2009 |
1 | Type I Tumor Necrosis Factor ReceptorsIBA
12/2004 |
1 | Messenger RNA (mRNA)IBA
04/2004 |
1 | OxindolesIBA
07/2003 |
1 | Oncogene Proteins (Oncogene Protein)IBA
07/2003 |
1 | SurvivinIBA
08/2002 |
1 | Docetaxel (Taxotere)FDA Link
08/2002 |
1 | Gefitinib (Iressa)FDA Link
12/2001 |
1 | Antisense OligonucleotidesIBA
12/2001 |
1 | Castor Oil (Oil, Castor)IBA
11/2001 |
1 | Albumin-Bound PaclitaxelFDA Link
11/2001 |
1 | AlbuminsIBA
11/2001 |
1 | Hormones (Hormone)IBA
09/2001 |
1 | Mitoxantrone (Novantrone)FDA LinkGeneric
08/2001 |
1 | CamptothecinIBA
08/2001 |
1 | Multidrug Resistance-Associated ProteinsIBA
08/2001 |
1 | SugarsIBA
04/2001 |
1 | Anti-Bacterial Agents (Antibiotics)IBA
04/2001 |
1 | AminesIBA
02/2001 |
1 | IminesIBA
02/2001 |
1 | Type II DNA Topoisomerases (Topoisomerase II)IBA
01/2001 |
1 | losoxantroneIBA
01/2001 |
1 | Protein Isoforms (Isoforms)IBA
01/2001 |
1 | BBR 3438IBA
01/2001 |
1 | 9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA
10/2000 |
1 | 7-cyanocamptothecinIBA
10/2000 |
1 | NF-kappa B (NF-kB)IBA
08/2000 |
1 | Transcription Factors (Transcription Factor)IBA
08/2000 |
1 | Sulfhydryl Compounds (Thiols)IBA
08/2000 |
1 | Membrane Proteins (Integral Membrane Proteins)IBA
08/2000 |
1 | Cytotoxins (Cytolysins)IBA
07/2000 |